First Time Loading...

Australian Clinical Labs Ltd
ASX:ACL

Watchlist Manager
Australian Clinical Labs Ltd Logo
Australian Clinical Labs Ltd
ASX:ACL
Watchlist
Price: 2.44 AUD 1.24% Market Closed
Updated: May 4, 2024

Australian Clinical Labs Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Australian Clinical Labs Ltd
Revenue Peer Comparison

Comparables:
HLA
SHL
IDX
CAJ
H
HLS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Australian Clinical Labs Ltd
ASX:ACL
Revenue
AU$995.6m
CAGR 3-Years
30%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Healthia Ltd
ASX:HLA
Revenue
AU$252.6m
CAGR 3-Years
43%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Sonic Healthcare Ltd
ASX:SHL
Revenue
AU$8.4B
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
9%
Integral Diagnostics Ltd
ASX:IDX
Revenue
AU$456.3m
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Capitol Health Ltd
ASX:CAJ
Revenue
AU$229.3m
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
12%
H
Healius Ltd
ASX:HLS
Revenue
AU$1.7B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
1%

See Also

What is Australian Clinical Labs Ltd's Revenue?
Revenue
995.6m AUD

Based on the financial report for Jun 30, 2022, Australian Clinical Labs Ltd's Revenue amounts to 995.6m AUD.

What is Australian Clinical Labs Ltd's Revenue growth rate?
Revenue CAGR 5Y
24%

Over the last year, the Revenue growth was 54%. The average annual Revenue growth rates for Australian Clinical Labs Ltd have been 30% over the past three years , 24% over the past five years .